Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Bioventix
Bioventix logo

BVXP - Bioventix News Announcements

4200p -125.0  -2.9%

Last Trade - 4:40pm

Sector
Healthcare
RiskRating
Adventurous
Size
Small Cap
Style
Falling Star
Market Cap £225.3m
Enterprise Value £217.2m
Revenue £10.3m
Position in Universe 791st / 1809
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BVXP Dividends
Company Announcements
All News Reuters News Company Announcements
BioVentix PLC - Price Monitoring Extension
4:35pm Annoucement
Bioventix Plc: Result of AGM
10th Dec '20 Annoucement
Bioventix Plc: Posting of Annual Report and Notice of AGM
16th Nov '20 Annoucement
Bioventix Plc: Holding(s) in Company
27th Oct '20 Annoucement
Bioventix Plc: Results for the year ended 30 June 2020
19th Oct '20 Annoucement
Bioventix Plc: Holding(s) in Company
20th Aug '20 Annoucement
Bioventix Plc: Issue of Equity
8th Jul '20 Annoucement
Bioventix Plc: Appointment of CFO
2nd Jul '20 Annoucement
Bioventix Plc: Appointment of CFO
1st Jul '20 Annoucement
Bioventix Plc: Director/PDMR Shareholding
2nd Apr '20 Annoucement
Bioventix Plc: Correction : Interim Results
31st Mar '20 Annoucement
BioVentix PLC - Second Price Monitoring Extn
30th Mar '20 Annoucement
BioVentix PLC - Price Monitoring Extension
30th Mar '20 Annoucement
BioVentix PLC - Second Price Monitoring Extn
30th Mar '20 Annoucement
BioVentix PLC - Price Monitoring Extension
30th Mar '20 Annoucement
Bioventix Plc: Interim Results
30th Mar '20 Annoucement
BioVentix PLC - Second Price Monitoring Extn
16th Mar '20 Annoucement
BioVentix PLC - Price Monitoring Extension
16th Mar '20 Annoucement
BioVentix PLC - Second Price Monitoring Extn
16th Mar '20 Annoucement
BioVentix PLC - Price Monitoring Extension
16th Mar '20 Annoucement
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.